Koyfin Home > Directory > Health Care > Adamas Pharma > Preferred Equity

Adamas Pharma Preferred Equity Chart (ADMS)

Adamas Pharma annual/quarterly Preferred Equity from 2012 to 2014.
  • Adamas Pharma Preferred Equity for the quarter ending March 03, 2014 was $27m a 22.85% increase of 6m year over year
  • Adamas Pharma Preferred Equity for the last 12 months ending March 03, 2014 was $27m a 22.85% increase of 6m year over year
  • Adamas Pharma Annual Preferred Equity for 2013 was $25m a 17.83% increase of 5m from 2012
  • Adamas Pharma Annual Preferred Equity for 2012 was $21m a 25.95% increase of 5m from 2011
  • Adamas Pharma Annual Preferred Equity for 2011 was $15m
Other Balance Sheet Metrics:
  • Adamas Pharma Total Assets for the quarter ending September 09, 2018 was $257m a 27.59% increase of 71m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
  • Adamas Pharma Total Equity for the quarter ending September 09, 2018 was $114m a 42.20% increase of 48m year over year
View Chart On Koyfin

Quarterly ADMS Preferred Equity Data

03/2014$27m
12/2013$25m
09/2013$22m
03/2013$21m
12/2012$21m

Annual ADMS Preferred Equity Data

2013$25m
2012$21m
2011$15m